Evidence map›Paper›PMID 23921993›Full record

ArticleAnnals of the rheumatic diseases2014

The effect of FTO variation on increased osteoarthritis risk is mediated through body mass index: a Mendelian randomisation study.

Kalliope Panoutsopoulou, Sarah Metrustry, Sally A Doherty, Laura L Laslett, Rose A Maciewicz, Deborah J Hart, Weiya Zhang, Kenneth R Muir, Margaret Wheeler, Cyrus Cooper and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Smooth muscle cell FTO regulates contractile function.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 4 countries.

Kalliope PanoutsopoulouWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Sarah MetrustryDepartment of Twin Research, King's College London, St Thomas' Hospital, London, UK.
Sally A DohertyAcademic Rheumatology, Nottingham City Hospital, Nottingham, UK.
Laura L LaslettMenzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.
Rose A MaciewiczRespiratory & Inflammation iMed, AstraZeneca, Mölndal, Sweden.
Deborah J HartDepartment of Twin Research, King's College London, St Thomas' Hospital, London, UK.
Weiya ZhangAcademic Rheumatology, Nottingham City Hospital, Nottingham, UK.
Kenneth R MuirCentre for Epidemiology, Institute of Population Health, The Medical School, University of Manchester, Manchester, UK Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.
Margaret WheelerAcademic Rheumatology, Nottingham City Hospital, Nottingham, UK.
Cyrus CooperNIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Tim D SpectorDepartment of Twin Research, King's College London, St Thomas' Hospital, London, UK.
Flavia M CicuttiniDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia.
Graeme JonesMenzies Research Institute Tasmania, University of Tasmania, Hobart, Australia.
Nigel K ArdenNIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Michael DohertyAcademic Rheumatology, Nottingham City Hospital, Nottingham, UK.
Eleftheria ZegginiWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Ana M ValdesDepartment of Twin Research, King's College London, St Thomas' Hospital, London, UK Academic Rheumatology, Nottingham City Hospital, Nottingham, UK.
arcOGEN Consortium
Nottingham City Hospital · GBKing's College London · GBUniversity of Tasmania · AUAstraZeneca (United Kingdom) · GBMonash University · AUSouthampton General Hospital · GBSt Thomas' Hospital · GBWellcome Sanger Institute · GBWellcome Trust · GB

Funding

Medical Research Council MC_U122886349Medical Research Council MC_U147585819Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12023/14Versus Arthritis 19542Wellcome Trust
6 · The paper itself

Abstract

objectiveVariation in the fat mass and obesity-associated (FTO) gene influences susceptibility to obesity. A variant in the FTO gene has been implicated in genetic risk to osteoarthritis (OA). We examined the role of the FTO polymorphism rs8044769 in risk of knee and hip OA in cases and controls incorporating body mass index (BMI) information.

methods5409 knee OA patients, 4355 hip OA patients and up to 5362 healthy controls from 7 independent cohorts from the UK and Australia were genotyped for rs8044769. The association of the FTO variant with OA was investigated in case/control analyses with and without BMI adjustment and in analyses matched for BMI category. A mendelian randomisation approach was employed using the FTO variant as the instrumental variable to evaluate the role of overweight on OA.

resultsIn the meta-analysis of all overweight (BMI≥25) samples versus normal-weight controls irrespective of OA status the association of rs8044769 with overweight is highly significant (OR[CIs] for allele G=1.14 [01.08 to 1.19], p=7.5×10(-7)). A significant association with knee OA is present in the analysis without BMI adjustment (OR[CIs]=1.08[1.02 to 1.14], p=0.009) but the signal fully attenuates after BMI adjustment (OR[CIs]=0.99[0.93 to 1.05], p=0.666). We observe no evidence for association in the BMI-matched meta-analyses. Using mendelian randomisation approaches we confirm the causal role of overweight on OA.

conclusionsOur data highlight the contribution of genetic risk to overweight in defining risk to OA but the association is exclusively mediated by the effect on BMI. This is consistent with what is known of the biology of the FTO gene and supports the causative role of high BMI in OA.

Indexed as

Gene-Environment InteractionMendelian Randomization AnalysisAgedAlpha-Ketoglutarate-Dependent Dioxygenase FTOBody Mass IndexCase-Control StudiesFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedObesityOsteoarthritis, HipOsteoarthritis, KneeOverweightPolymorphism, Single NucleotideAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanProteinsEpidemiologyGene PolymorphismKnee OsteoarthritisOsteoarthritis

Identifiers

PMID23921993
PMCPMC4251538
OpenAlexW2132788916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.